CorMedix Inc.
CRMD
$10.32
$0.545.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4,009.64% | 240.11% | 242.71% | 191.26% | 71.50% |
| Total Depreciation and Amortization | 4,797.29% | 111.83% | 642.66% | 614.97% | 334.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,515.37% | 108.42% | 43.01% | 9.34% | 21.98% |
| Change in Net Operating Assets | -109.99% | 676.07% | 13.66% | -851.82% | -156,506.41% |
| Cash from Operations | 326.06% | 313.62% | 214.02% | 47.75% | -56.94% |
| Capital Expenditure | -5,061.22% | 31.32% | 83.36% | 96.65% | 3.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 203.06% | -420.27% | -102.05% | -132.93% | 1,198.01% |
| Cash from Investing | -4,708.48% | -422.43% | -102.18% | -150.89% | 1,177.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.57% | 6,880.16% | -- | 2,324.18% | -67.19% |
| Repurchase of Common Stock | -- | -77.42% | -949.43% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 969.54% | 7,778.31% | 6,374.87% | 2,312.83% | -67.19% |
| Foreign Exchange rate Adjustments | -25.00% | 900.00% | 125.00% | -150.00% | 119.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,729.55% | 1,485.34% | 402.89% | 155.44% | -79.93% |